Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4152231:0-csbr-q1-revenue-up-9-year-over-year-gross-margin-at-50-and-data-revenue-surged-past-last-year-s-total

CSBR: Q1 revenue up 9% year-over-year, gross margin at 50%, and data revenue surged past last year's total

2+ day, 7+ hour ago   (87+ words) TradingView CSBR: Q1 revenue up 9% year-over-year, gross margin at 50%, and data revenue surged past last year's total Revenue grew 9% year-over-year to $15.2 million, with gross margin rising to 50% and adjusted EBITDA positive for the fifth consecutive quarter. Data licensing revenue exceeded the…...

Pulse 2.0
pulse2.com > itaconix-h1-revenue-jumps-72-to-8-3-million-as-company-reaches-break-even-adjusted-ebitda

Itaconix: H1 Revenue Jumps 72% To $8.3 Million As Company Reaches Break-Even Adjusted EBITDA

2+ day, 10+ hour ago   (237+ words) Itaconix reported record first-half 2026 revenue of $8.3 million, up 72% year over year, as increasing adoption of its plant-based specialty polymers drove substantial growth in its Performance Ingredients business. Itaconix Performance Ingredients revenue increased 104% to $6.7 million, while SPARX Formulated Solutions revenue increased…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4150781:0-inva-specialty-therapeutics-and-innovative-drug-delivery-drive-growth-with-resilient-royalty-streams-funding-expansion

INVA: Specialty therapeutics and innovative drug delivery drive growth, with resilient royalty streams funding expansion

2+ day, 15+ hour ago   (79+ words) TradingView INVA: Specialty therapeutics and innovative drug delivery drive growth, with resilient royalty streams funding expansion Specialty therapeutics revenue exceeded $200 million, driven by XACDURO and GIAPREZA, with strong U.S. and ex-U.S. growth. Nortiva's LYNX platform targets once-monthly oral contraceptives, supported by…...

StorageNewsletter
storagenewsletter.com > 09/09/2026 > snowflake-fiscal-2q27-financial-results

Snowflake: Fiscal 2Q27 Financial Results

3+ day, 16+ hour ago   (326+ words) StorageNewsletter - -- More resources -- Complete List of 235 SSD Makers All Financial Rounds of Funding of Storage Start-Ups Since 2000 All M&As in 2023 All Companies in All-Flash Subsystems Storage Dictionary (SNIA) History of Storage Industry Storage Abbreviations Top Fastest Growing Storage Companies…...

The National Law Review
natlawreview.com > press-releases > lokahi-therapeuticstm-expands-ai2-three-opportunity-creating-business

Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions

4+ day, 14+ hour ago   (395+ words) The National Law Review Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions ai² Pipeline™, ai² Talent™, and ai² Accelerator™ create potential revenue-generating opportunities while strengthening Lōkahi's therapeutic development platform. RUTHERFORD, N.J., & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™ Inc., a subsidiary of…...

NERDBOT
nerdbot.com > 09/08/2026 > record-revenue-expensive-money-and-weak-currencies-endo-ryuki-on-the-numbers-behind-business

Record Revenue, Expensive Money and Weak Currencies

4+ day, 18+ hour ago   (632+ words) ​Corporate headlines can make business look deceptively simple. Revenue is up. Profits are down. Wages are rising. The currency is weakening. Interest rates changed. ​But those numbers rarely operate independently. ​In this Q&A, Endo Ryuki, Senior Broker at MizoraTrade,…...

@kalkineca
kalkinemedia.com > ca > news > featured-news > kane-biotech-tsx-v-kne-unlocks-ontario-health-athome-formulary-access-through-oms-partnership-1

Kane Biotech (TSX-V: KNE) Unlocks Ontario Health atHome Formulary Access Through OMS Partnership

6+ day, 3+ hour ago   (315+ words) Millions of patients. Tens of millions of nursing visits. And at the center of it all, a stubborn clinical challenge that drains resources and resists conventional treatment. Kane Biotech (TSX-V:KNE) is moving decisively into this space, and its latest…...

Google News
rubinobservatory.org > explore > rubin-basics > data-releases

Data Releases

6+ day, 12+ hour ago   (173+ words) NSF is an independent federal agency created by Congress in 1950 to promote the progress of science. NSF supports basic research and people to create knowledge that transforms the future. The DOE Office of Science is the single largest supporter of…...

StorageNewsletter
storagenewsletter.com > 09/03/2026 > dell-technologies-fiscal-2q27-financial-results

Dell Technologies: Fiscal 2Q27 Financial Results

1+ week, 2+ day ago   (274+ words) StorageNewsletter - -- More resources -- Complete List of 235 SSD Makers All Financial Rounds of Funding of Storage Start-Ups Since 2000 All M&As in 2023 All Companies in All-Flash Subsystems Storage Dictionary (SNIA) History of Storage Industry Storage Abbreviations Top Fastest Growing Storage Companies…...

C3 AI
c3.ai > news > c3-ai-announces-fiscal-first-quarter-2027-results

C3 AI Announces Fiscal First Quarter 2027 Results

1+ week, 3+ day ago   (196+ words) Bookings increase 73% quarter over quarter REDWOOD CITY, Calif. — September 2, 2026 — C3.ai, Inc. (“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise AI application software company, today announced financial results for its fiscal first quarter ended July 31, 2026. The Company closed 22 agreements including with…...